NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE116907 Query DataSets for GSE116907
Status Public on Jul 09, 2019
Title Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq)
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Summary Three triple negative breast cancer cell lines (MDAMB231, SUM159, and HCC1806) were treated with small molecule inhibitors (JQ1, BET bromodomain inhibitor; GSK2801, BAZ2A/B bromodomain inhibitor) alone and in combination for 72 hours
 
Overall design 12 experimental samples
 
Contributor(s) Johnson GL, Bevill SM
Citation(s) 31000582
Submission date Jul 10, 2018
Last update date Oct 08, 2019
Contact name Gary L Johnson
E-mail(s) glj@med.unc.edu
Phone 919-843-3107
Organization name UNC Chapel Hill SOM
Department Pharmacology
Lab Gary L. Johnson
Street address 120 Mason Farm Road Genetic Medicine Building CB#7365
City Chapel Hill
State/province North Carolina
ZIP/Postal code 27599
Country USA
 
Platforms (1)
GPL18573 Illumina NextSeq 500 (Homo sapiens)
Samples (12)
GSM3263568 SUM159_DMSO_72hr
GSM3263569 SUM159_300nM_JQ1_72hr
GSM3263570 SUM159_10uM_GSK2801_72hr
This SubSeries is part of SuperSeries:
GSE116919 Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination
Relations
BioProject PRJNA480603
SRA SRP153037

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE116907_RAW.tar 2.0 Mb (http)(custom) TAR (of TXT)
SRA Run SelectorHelp
Raw data are available in SRA
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap